CHARLES SCHWAB INVESTMENT MANAGEMENT INC - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 92 filers reported holding SPERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,564
-16.6%
28,5650.0%0.00%
Q2 2023$41,4190.0%28,5650.0%0.00%
Q1 2023$41,419
-16.2%
28,5650.0%0.00%
Q4 2022$49,417
-91.3%
28,565
-56.4%
0.00%
Q1 2022$571,000
-45.6%
65,5470.0%0.00%
Q4 2021$1,050,000
-10.3%
65,547
+3.1%
0.00%
Q3 2021$1,171,000
+38.6%
63,586
+5.1%
0.00%
Q2 2021$845,000
+7.5%
60,496
+13.4%
0.00%
Q1 2021$786,000
-21.9%
53,358
+2.9%
0.00%
Q4 2020$1,006,000
+154.0%
51,831
+46.2%
0.00%
Q3 2020$396,000
-17.5%
35,4540.0%0.00%
Q2 2020$480,000
+89.0%
35,454
+13.0%
0.00%
Q1 2020$254,000
-3.1%
31,364
+15.2%
0.00%
Q4 2019$262,000
-9.3%
27,2260.0%0.00%
Q3 2019$289,000
-0.3%
27,226
+8.4%
0.00%
Q2 2019$290,000
+17.4%
25,118
+30.7%
0.00%
Q1 2019$247,000
+174.4%
19,223
+32.3%
0.00%
Q4 2018$90,000
-41.2%
14,5270.0%0.00%
Q3 2018$153,00014,5270.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders